U-Blot® Research Grade CobolimabCat. No. WA2620$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade CobolimabCat. No. WA2620
U-Blot® Research Grade CM101Cat. No. WA2619
U-Blot® Research Grade ClivatuzumabCat. No. WA2618
U-Blot® Research Grade cliramitugCat. No. WA2617
U-Blot® Research Grade ClesrovimabCat. No. WA2616
U-Blot® Research Grade clesitamigCat. No. WA2615
U-Blot® Research Grade Clervonafusp AlfaCat. No. WA2614
U-Blot® Research Grade Clervonafusp AlfaCat. No. WA2613
U-Blot® Research Grade ClenoliximabCat. No. WA2612
U-Blot® Research Grade ClazakizumabCat. No. WA2611
U-Blot® Research Grade claseprubartCat. No. WA2610
U-Blot® Research Grade CizutamigCat. No. WA2609